RE: So where is.....28 Aug 2025 10:59
Your name certainly fits.
This was stated at the very end of June
As a Board, we remain focused on bringing our two key late-stage clinical assets, P140 for SLE and CIDP, closer to the market, and securing additional global partnering deals for P140 together with our earlier stage assets.
Global partnerships sounds very impressive.
Just a case of a little waiting and hopefully see this fly with a couple of deals.